Renalytix AI (GB:RENX) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Renalytix plc has published its 2024 Annual Report and announced the date for its Annual General Meeting, set for December 19 in London. As a leader in AI-driven diagnostics for kidney health, Renalytix is committed to enhancing patient outcomes and reducing healthcare costs through its innovative solutions. Investors and shareholders are encouraged to review the report and participate in the meeting to stay informed about the company’s future directions.
For further insights into GB:RENX stock, check out TipRanks’ Stock Analysis page.
